Polymorphism of ApoE in Alzheimer's Disease: Genetic Study in Castile and Leon (Spain) - Trial NCT06275243
Access comprehensive clinical trial information for NCT06275243 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad de León and is currently Recruitment Completed. The study focuses on Alzheimer Disease. Target enrollment is 511 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universidad de León
Timeline & Enrollment
N/A
Jul 06, 2022
Mar 22, 2024
Primary Outcome
Distribution of ApoE variants in the Alzheimer's disease population diagnosed in Castile and Leon.
Summary
The general objective of this randomized and longitudinal clinical study was to estimate the
 frequencies of ApoE variants both in the user population of the Messengers of Peace
 Residences and the Associations of Relatives of Alzheimer's Patients in Castile y Leon,
 since, due to its geographical location at the crossroads, it has received multiple genetic
 contributions from both northern Europe, the Mediterranean area and northern Africa.
 
 The main questions it aims to answer are:
 
 - What are the allelic frequencies of ApoE variants in the population of individuals with
 Alzheimer's disease in Castile and Leon?
 
 - Is there a correlation between the ApoE4 variant and the lipid profile in the blood of
 individuals with Alzheimer's disease in this region?
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06275243
Non-Device Trial